Danilon Equidos (pack of 60 sachets)

Target species Equines. Indications for use Treatment of pain and inflammation associated with musculo-skeletal conditions in the horse eg osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation. Contra-indications Do not administer to animals with renal, hepatic or cardiac disorders; where there is the possibility of gastro-intestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia or hypersensitivity to the product. Avoid use in dehydrated, hypovolemic or hypotensive animals as there is an increased risk of renal failure. Special warnings for each target species Do not administer to horses prior to taking part in a competition. During treatment of very young animals (less than 12 weeks) where development of their hepatic or renal function may be incomplete, or in aged animals which may have these functions impaired, as well as in ponies, additional risk may be involved. In these cases, doses should be accurately calculated and patients monitored closely. During treatment, do not restrict the consumption of water. Avoid use in any dehydrated, hypovolaemic or hypotensive animals as there may be an increased risk of renal failure. NSAIDs can cause inhibition of phagocytosis and hence, in the treatment of inflammatory conditions associated with bacterial infections appropriate antimicrobial therapy should be instigated. Special precautions for use Special precautions for use in animals During treatment do not restrict the consumption of water. Use in very young or aged animals and ponies may involve additional risk. Adjust the dose to bodyweight and closely monitor clinical response. Do not exceed the stated dose or duration of treatment. Dosage should be kept to a minimum for alleviation of symptoms. Special precautions to be taken by the person administering the product to the animals Wear suitable gloves. Wash hands after use. Use in a well-ventilated area. Avoid inhaling any dust when opening sachet and mixing with feed. In case of accidental contact with eyes, wash immediately with plenty of clean water. In case of accidental ingestion, seek medical advice immediately and show this label to the physician. Adverse reactions (frequency and seriousness) After continued use, or at high doses gastro-intestinal changes may occur. Occasionally blood dyscrasias and renal alterations may be found, especially in animals with restricted access to water. Use during pregnancy and lactation Studies have not been carried out in the horse to establish safe use during pregnancy and lactation. Interaction with other veterinary medicinal products and other forms of interaction Suxibuzone and its metabolites may be highly bound to plasma proteins and compete with other highly bound drugs eg sulphonamides, warfarin; or it may itself be displaced to produce an increase of non-bound pharmacologically active concentrations which could lead to toxic effects. Drug compatibility must be closely monitored when adjunctive therapy is required. Do not administer together with other NSAIDs concurrently or within 24 hours of each other. Concurrent administration of potentially nephrotoxic drugs should be avoided.
Vat Rate: 20%